bay n 7133 has been researched along with cilofungin in 1 studies
| Studies (bay n 7133) | Trials (bay n 7133) | Recent Studies (post-2010) (bay n 7133) | Studies (cilofungin) | Trials (cilofungin) | Recent Studies (post-2010) (cilofungin) |
|---|---|---|---|---|---|
| 37 | 1 | 0 | 83 | 1 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fromtling, RA; Shadomy, S; Yu, HP | 1 |
1 other study(ies) available for bay n 7133 and cilofungin
| Article | Year |
|---|---|
In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
Topics: Antifungal Agents; Candida; Candida albicans; Cryptococcus; Cryptococcus neoformans; Culture Media; Echinocandins; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Triazoles | 1984 |